NCT07430202 2026-05-06A DNAJB1-PRKACA Fusion Kinase Peptide Vaccine Combined With Glutamine Antagonist DRP-104, Nivolumab, and Ipilimumab in Patients With Advanced Stage Fibrolamellar Carcinoma (FLC)Sidney Kimmel Comprehensive Cancer Center at Johns HopkinsPhase 1 Not yet recruiting27 enrolled